APDM was founded with the objective of creating novel technologies to

  1. enable the scientific community to conduct quality research in movement science,
  2. accelerate clinical trials by introducing a new generation of biomarkers and validated endpoints, and
  3. improve the quality of life of people with movement disorders through precision medicine for neurodegenerative diseases.

FOUNDED 2007

Longest tenured team in wearable movement science industry

1,000+ CLIENTS

Researchers globally utilizing APDM technology

350+ PUBLICATIONS

Gold standard technology for precision motion analytics

FOUNDATIONAL PATENTS

Portfolio with patents (sensors, systems, & methods) dating back to 2008

100+ OUTCOMES

Validated outcomes/endpoints ready for use in your study

45,000+ CITATIONS

World-class scholars in motion science, movement disorders, and biomedical signal processing

APDM, AN ERT COMPANY

ERT, the leader in clinical endpoints data collection, has acquired APDM Wearable Technologies. The combined company will generate higher-fidelity and more powerful data to enable clinical trials to be more predictable, cost-effective, and efficient. Thereby, reinventing endpoint measurement.

COMPANY HISTORY

APDM’s platform has been validated by the top world researchers for over 10 years and has hundreds of scientific publications and studies validating the technology and outcome measures.